source
- FDA advisory panel to decide on compounding of synthetic peptides amid safety concernsThe FDA advisory committee is meeting to consider whether compounding pharmacies should be allowed to manufacture seven specific synthetic peptides. Use of these peptides has grown in the United St…
- Merck CEO warns Congress that restricting US-China biotech deals could cost America its biotech leadershipMerck CEO Rob Davis told Congress and the Trump administration that limiting or cutting off US-China dealmaking would jeopardize US biotech leadership. He emphasized that collaboration with Chines…